Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Omeros Stock Quote


Price as of May 24, 2024, 4:00 p.m. ET

Omeros Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
OMER -41.43% -81.24% -28.42% -62%
S&P +27.79% +87.71% +13.41% +398%

Omeros Company Info

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

News & Analysis

The Fool has written over 100 articles on Omeros.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.